In addition, the inhibition of the APC/β-catenin/TCF4 pathway in colon cancer cells by the forced expression of a transfected, dominant negative TCF4 variant also leads to increased SERCA3 expression [85]. This evidence concerns the gene TCF4 and colonic neoplasm.